| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |